Foretinib

Foretinib
Item number Size Datasheet Manual SDS Delivery time Quantity Price
LKT-F5968.5 5 mg -

3 - 8 business days*

144.00€
LKT-F5968.10 10 mg -

3 - 8 business days*

216.00€
LKT-F5968.25 25 mg -

3 - 8 business days*

421.00€
 
Foretinib is an inhibitor of ROS1, MET, Ron, Axl, Tie-2, and VEGFR2 that exhibits anticancer... more
Product information "Foretinib"
Foretinib is an inhibitor of ROS1, MET, Ron, Axl, Tie-2, and VEGFR2 that exhibits anticancer chemotherapeutic and anti-angiogenic activities. In subjects with squamous cell carcinoma, foretinib decreases tumor size. In hepatocellular carcinoma cells, foretinib increases expression of p27 and Bim, decreases expression of cyclin B1 and p-c-Myc, and induces G2/M phase cell cycle arrest, inhibiting cell growth and migration as well as tumor growth and angiogenesis.
Keywords: GSK-1363089, GSK1363089
Supplier: LKT Laboratories
Supplier-Nr: F5968

Properties

Application: VEGFR2 tyrosine kinase inhibitor, Met proto-oncogene (c-Met) inhibitor
MW: 632.65 D
Purity: >98%
Format: Solid

Database Information

CAS : 849217-64-7| Matching products
KEGG ID : K05098 | Matching products

Handling & Safety

Storage: +20°C
Shipping: +20°C (International: +20°C)
Signal Word: Warning
GHS Hazard Pictograms:
H Phrases: H302, H373
P Phrases: P260, P264, P270, P301+P312, P314, P330, P501
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Foretinib"
Write a review
or to review a product.
Viewed